Showing results (301-310 of 309) with videos related to
Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 309 results.
Journal of Ayurveda and Integrative Medicine|March 3, 2021
In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main proteaseThrigulla Saketh Ram, Manne Munikumar, Vankudavath Naik Raju, et al.Physical Review Letters|November 17, 2018
Superallowed α Decay to Doubly Magic ^{100}SnK Auranen, D Seweryniak, M Albers, et al.Physical Review Letters|July 22, 2015
First Direct Measurement of (12)C((12)C,n)(23)Mg at Stellar EnergiesB Bucher, X D Tang, X Fang, et al.Nature|March 14, 2024
Mitochondrial complex I activity in microglia sustains neuroinflammationL Peruzzotti-Jametti, C M Willis, G Krzak, et al.PNAS Nexus|August 7, 2024
Ocean weather, biological rates, and unexplained global ecological patternsDarren L C Y Li Shing Hiung, Jasmin M Schuster, Murray I Duncan, et al.Plos One|April 7, 2017
Correction: Evaluation of 19,460 Wheat Accessions Conserved in the Indian National Genebank to Identify New Sources of Resistance to Rust and Spot Blotch DiseasesSundeep Kumar, Sunil Archak, R K Tyagi, et al.Plos One|December 13, 2016
Evaluation of 19,460 Wheat Accessions Conserved in the Indian National Genebank to Identify New Sources of Resistance to Rust and Spot Blotch DiseasesSundeep Kumar, Sunil Archak, R K Tyagi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.Applied Optics|May 11, 2010
Research on nonlinear optical materials: an assessmentD H Auston, A A Ballman, P Bhattacharya, et al.Pageof 31